Registration Dossier

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

No skin sensitisation study with calcium dibenzoate is available, thus the skin sensitisation potential will be addressed with existing data on the individual moieties calcium and benzoate.

 

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

Calcium dibenzoate is not expected to have a skin sensitising activity, since the two moieties calcium and benzoate respectively benzoic acid have not shown any skin sensitisation potential in experimental testing. Further testing is not required. For further information on the toxicity of the individual moieties, please refer to the relevant sections in the IUCLID and CSR.

 

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

As the two moieties of calcium dibenzoate are not sensitising, calcium dibenzoate in all probability has also no sensitising activity.

According to the criteria of REGULATION (EC) No 1272/2008 and its subsequent adaptions, calcium dibenzoate does not have to be classified and has no obligatory labelling requirement for sensitization by skin contact.

Calcium dibenzoate is not classified for respiratory sensitisation because of lacking data.